Today: 20 May 2026
UOB stock price edges higher as Singapore banks trade near record levels ahead of earnings
4 February 2026
1 min read

UOB stock price edges higher as Singapore banks trade near record levels ahead of earnings

Singapore, February 4, 2026, 15:11 SGT — Regular session

Shares of United Overseas Bank Ltd (SGX: U11) rose 0.13% to S$38.48 by 2:46 p.m. in Singapore, up 5 cents on the day. About 796,000 shares had traded, with the stock opening at S$38.18 after closing at S$38.43 on Tuesday.

The muted move comes a session after Singapore stocks notched another record close, with banks again in the mix. The Straits Times Index ended Tuesday up 1.1% at 4,944.09, while DBS rose 0.3% to S$59.05, OCBC gained 0.9% to S$21.28 and UOB added 0.1% to S$38.43.

That matters now because the next leg for Singapore bank shares usually comes from guidance, not momentum. Investors are bracing for management tone on net interest margin — the spread between what a bank earns on loans and pays for funding — and any read-through on credit demand.

Outside the banks, Singtel remained a market talking point after it agreed to buy data centre firm ST Telemedia Global Data Centres with KKR and Temasek. “It cements Singtel as one of the largest data centre operators in Asia,” Phillip Securities’ head of research Paul Chew said. Reuters

SGX cash equities trade through an opening routine before 09:00, then a morning session to 12:00 and an afternoon session from 13:00 to 17:00, followed by a closing routine. Wednesday’s UOB move came during the afternoon trading window.

UOB has stayed within a tight band, with the day’s range at S$38.18 to S$38.49, leaving it within reach of its 52-week high of S$39.50. Stock Analysis put the bank’s market value around S$63.5 billion.

But there is a downside case: margins may not hold up if funding costs stay sticky while loan yields ease. In its last quarterly update, UOB said it expects 2026 net interest margin of 1.75% to 1.80%, below the projected 1.85% to 1.90% for 2025, after heavier credit allowances hit profit; CEO Wee Ee Cheong said it had “proactively set aside general allowances to significantly enhance provision coverage”. Reuters

The next hard catalyst is UOB’s FY25/4Q25 results on Feb. 24, according to its investor calendar. Traders will be watching for any shift in dividend messaging and for clues on margins and asset quality into 2026.

Stock Market Today

  • Sea Limited (NYSE:SE) Valuation Under Scrutiny After 46% One-Year Share Decline
    May 20, 2026, 10:05 AM EDT. Sea Limited (NYSE:SE), active across e-commerce, digital financial services, and digital entertainment in Southeast Asia and Latin America, has seen its stock fall by 46.26% over the past year. Despite recent share price weakness, some analysts argue the stock trades 36.6% below a $137.64 fair value estimate, buoyed by strong revenue growth from Shopee, Monee, and Garena platforms. Key drivers include accelerating mobile internet penetration, youth digital literacy, and shifts toward cashless payments supporting loan book expansion and improved monetization. Market watchers debate whether this dip offers a buying opportunity or reflects tempered growth prospects, especially as Shopee faces competitive pressures. Investors should weigh Sea's potential for earnings growth against market realities and execution risks.

Latest articles

Vida CEO Steps In as $15 Million AI IPO Hits Reality Check

Vida CEO Steps In as $15 Million AI IPO Hits Reality Check

20 May 2026
Vida Global Inc. raised $15 million in its May 18 IPO, selling 3.75 million shares at $4 each, but the stock closed at $2.29 on Tuesday. CEO Lyle Pratt bought 312,900 shares for about $1.19 million, according to a Form 4 filing. Vida reported 2025 revenue of $551,383 and a net loss of $2.9 million. The company’s shares trade on NYSE American and NYSE Texas under the symbol VIDA.
TJX Shares Rise Premarket As T.J. Maxx Parent Raises Outlook

TJX Shares Rise Premarket As T.J. Maxx Parent Raises Outlook

20 May 2026
TJX raised its fiscal 2027 sales, earnings, and buyback targets after first-quarter comparable sales rose 6% and net income hit $1.3 billion. Shares climbed 3.6% in premarket trading. The company cited higher fuel costs as a drag on its full-year forecast. Marmaxx, HomeGoods, and TJX Canada all posted strong sales growth.
ImmunityBio in the Spotlight with Patents and BCG Deal Ahead of the Open

ImmunityBio Faces FDA Decision on Bladder-Cancer Application, Risk Remains

20 May 2026
The FDA accepted ImmunityBio’s application to expand Anktiva’s use with BCG in papillary-only, BCG-unresponsive non-muscle invasive bladder cancer, setting a Jan. 6, 2027 decision date. ImmunityBio reported $44.2 million in first-quarter net product revenue and held $380.9 million in cash and equivalents. Shares last traded at $7.76, down 2.8%. The filing is supported by data from 80 patients in a Phase 2/3 trial.
BHP stock jumps nearly 5% as miners snap back — what investors watch before Feb. 17 results
Previous Story

BHP stock jumps nearly 5% as miners snap back — what investors watch before Feb. 17 results

Sage Group share price slips again: AI selloff hits SGE.L ahead of AGM
Next Story

Sage Group share price slips again: AI selloff hits SGE.L ahead of AGM

Go toTop